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BACKGROUND 
This document reflects requirements for the experiment 
entit1ed:"Autogenic Feedback Training (AFT): A Preventive Method 
for Space Adaptation Syndrome". AFT is a physiological training 
procedure that has been shown to significantly reduce the 
severity of motion sickness symptoms in ground-based tests. The 
above experiment has been accepted by NASA as a formal Life 
Sciences Shuttle flight study that will test the effectiveness of 
AFT for reducing the symptoms of SAS in Shuttle Flight crews. The 
final verification of AFT requires tests in space on 16 
individuals, 8 who were trained and 8 Control group subjects 
given an alternative treatment. This experiment has been flown on 
STS 51-C (a pilot study of hardware and procedures, no data 
obtained) and on STS 51-B, where data was collected on four 
crewmembers (2 trained and 2 controls). Initial results of 51-B 
were encouraging, indicating that AFT effectively eliminated the 
symptoms of one crewmember who had demonstrated proficiency in 
control of his physiological responses preflight. The second 
trained crewmember experienced one symptom briefly on mission day 
one, while both control subjects, who took anti-motion sickness 
drugs, experienced multiple symptom episodes. 
NASA, Ames Research Center and USAF Space Division (February, 
1986). The MOA outlines the intent to continue tests of AFT in 
space as a joint effort between these agencies, until the 
experiment goal of testing 16 individuals has been reached. 
A Memorandum of Agreement (MOA) has been signed between 
PURPOSE/OBJECTIVES 
1. To determine if preflight AFT is an effective treatment for 
SAS. Those subjects who receive AFT should experience fewer 
symptoms inflight than Control group subjects who receive no 
treatment or an alternative treatment. 
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2. To determine if preflight improvements in motion sickness 
tolerance can be used to predict crewmembers' success in 
controlling symptoms inflight. Crewmembers who demonstrate 
greater physiological control and are able to tolerate motion 
sickness stimulation significantly longer after training should 
experience fewer symptoms during the mission. 
3. To identify differences and similarities between the 
physiological data from preflight motion sickness tests and 
data collected during symptom episodes in space. 
TEST CONDITIONS/ACTIVITY REQUIRED 
1. BASELINE DATA COLLECTION (Treatment and Control Subjects) 
L-12 months 
a. 
b. 
C. 
d. 
e. 
Coriolis motion sickness test: The initial symptoms of motion 
sickness will be induced using a standard rotating chair or a 
rotating room called the Man Carrying Rotation Device (MCRD) at 
ARC. Physiological responses will be monitored and the 
individual's symptom characteristics will be documented. 
Vertical acceleration motion sickness test: Initial motion 
sickness symptoms will be induced using the Vertical Acceleration 
and Roll Device (VARD) at ARC. Physiological responses will be 
monitored and the individual's symptom characteristics will be 
documented. 
KC-135 Flights: Crewmembers will be required to wear an 
ambulatory monitoring garment and belt-worn instrument package 
containing biomedical instrumentation and a tape recorder while 
participating in micro-gravity maneuvers in the KC-135 aircraft 
at Ellis AFB. Any motion sickness symptoms occurring under flight 
conditions will be recorded and the individual's symptom 
characteristics will be documented. 
Resting Baseline Sessions: Physiological data will be 
recorded while crewmembers sit quietly in a reclining chair and 
listen to tape recorded music for a period of 30 minutes. These 
resting data will be compared to physiological data obtained in 
the above motion sickness tests and individual "stress profiles" 
will be generated. Resting baseline sessions are repeated twice. 
Joint Integrated Simulations (JIS) : A s  Scheduled by Mission 
Manager. Ambulatory physiological data will be recorded on each 
crewmember for a period (minimum) of 12 hours--the equivalent of 
one mission day. Using flight hardware (or high fidelity ground 
support hardware), the crewmember will perform all normal mission 
day activities. Data collection during JIS serves two purposes: 
(1) The effects of normal circadian shifts on physiological 
levels and changes due to payload activity related movement, but 
NOT DUE TO SAS, can be documented and subsequently compared to 
flight data; and (2) Any operational difficulties identified by 
the crewmember regarding comfort or ease of operation of flight 
hardware can be documented and corrected prior to the mission. 
2. AUTOGENIC FEEDBACK TRAINING SESSIONS (Treatment Subjects) 
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L-12 months I 
Treatment group subjects will be required to attend a total 
of 15 sessions (each 2 to 3 hours in duration). Optimally, these 
sessions should be administered on consecutive days. During 12 of 
these sessions the crewmember will receive training from the 
Principal Investigator and one co-investigator in control of his 
own autonomic responses. During 3 of these sessions, the 
crewmember will be given a rotating chair test to evaluate 
training effectiveness for the prevention and control of his 
motion sickness symptoms to suppress his symptoms. These sessions 
will be conducted at NASA/ARC. 
3. FOLLOW-UP AUTOGENIC FEEDBACK TRAINING SESSIONS (Treatment Subjects) 
L-4 TO L-1 months , 
A minimum of 4 and a maximum of 8 follow-up AFT sessions 
will be administered to crewmembers. These sessions will be 
conducted by the P.I. or designated co-Investigator, and can be 
performed at any location (maximum duration of 2 hours). 
Crewmembers will be given flight hardware (or high fidelity 
ground support equipment) to support this activity. The total 
number of follow-up sessions required will be determined by both 
the investigator and crewmember, and will be based on a review 
and discussion of his earlier training performance. 
At least one additional flight on the KC-135 aircraft must 
be scheduled during or after follow-up AFT sessions. This KC-135 
flight test will provide: (a) collection of physiological data 
for comparison to baseline KC-135 flights (flown at L-12 months); 
(b) an opportunity to apply AFT procedures to control motion 
sickness symptoms under ambulatory (micro-gravity) conditions. 
These data can be used to further evaluate training progress; and 
(c) practice in donning, doffing and operation of flight hardware 
under conditions that most closely simulate the actual mission. 
NOTE: For objectives (a) and (c), it is required that Control 
Group subjects also participate in these KC-135 flights. 
4. ADDITIONAL OPERATIONAL TRAINING (All subjects) 
L-4 TO L-1 months 
a. Diagnostic Scale Administration: All crewmembers 
participating in this experiment should attend a one-hour 
(minimum) review session on procedures. Crewmembers will be 
provided with Diagnostic log books that will be identical to 
those used inflight. This class can be administered at any 
location with the assistance of an investigator. 
b. One-G Trainer Class: This session will provide crewmembers 
with an opportunity to practice the following procedures using a 
written checklist: prelaunch activation of hardware, post-orbit 
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insertion procedures relevant to the AFT experiment, and location 
and identification of AFT stowage in middeck lockers. Crewmembers 
will use flight hardware or high fidelity ground support 
equipment, as well as final configuration stowage lockers. This 
activity should require no more than three hours and should be 
performed in the 1-g Shuttle mockup at NASA/JSC with the 
assistance of an investigator. Any changes in checklist 
procedures recommended by the crew can be evaluated and 
subsequently included in revised checklists. 
c. Flight Data File Book Review: Inflight procedures, both 
nominal and malfunction, will be reviewed and updated (as 
needed). Crewmembers (both Treatment and Control Group subjects) 
will be given an opportunity to work directly with flight 
hardware (or high fidelity ground support equipment) with the 
assistance of an investigator. This session includes practice in 
donning and doffing the ambulatory monitoring garment, attaching 
electrodes, transducers and cable harness, and operation of data 
recording hardware. This activity should require no more than 2 
hours and can be performed at any location. Crewmembers may opt 
for additional practice sessions if needed. 
5. FINAL AFT VERIFICATION SESSION (All Subjects) 
L-10 DAYS 
A final 2 hour (Maximum) AFT verification session will be 
conducted by the P.I. or designated co-investigator no later than 
one week prior to the launch. This session can be conducted at 
any location, and investigators will provide crewmembers with 
duplicate flight hardware. This session is essential to AFT 
science objectives because it enables: (a) evaluation of the 
crewmember's ability to control his physiological responses and, 
if needed, further instruction and practice can be given to 
enhance training effectiveness; and (b) documentation of any 
changes in resting physiological levels (of both Treatment and 
Control subjects) which have occurred during the L-12 months 
(when these data were first recorded) and the L-10 days period. 
These differences in physiological response levels will be used 
for evaluating flight data. 
6. PRELAUNCH ACTIVATION OF DATA RECORDER 
a. The ambulatory monitoring garment, transducers, electrodes, 
AFS and recorder should be donned at the time the crewmember 
dresses for launch. Activation of the instrument is performed to 
evaluate functional status. Malfunction procedures are performed 
(e.g., replace electrode) if needed and power to the instrument 
and recorder is TURNED OFF. 
b. After orbiter seat ingress, checklist procedures should be 
performed to initiate data recording (Start, approximately L-90 
minutes). 
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1. Timelined Activities: (All Subjects) 
(a) Continuously record physiological responses for the first 3 
mission days (12-waking hours). This activity will require 
donning of the ambulatory monitoring garment and hardware during 
post-sleep activity periods (10 minute duration). 
(b) Replace data cassette tapes daily. (5 minute duration) 
(c) Replace batteries daily. (5 minute duration) 
(d) Perform diagnostic scale (written 8-item checklist) twice daily. 
(Treatment Subjects only) 
(e) Perform daily preventive AFT session (15 minute duration). 
2. Symptom-Contingent Activities: (All Crewmembers) : 
(a) Press event button on personal recorder and perform 
diagnostic scale. 
(Treatment Subjects Only) 
(b) Perform counteractive AFT (30 minutes maximum duration) at 
any time that symptoms arise during the mission. Can be done 
while performing other mission payload activities. 
(c) Readminister diagnostic scale AFTER counteractive AFT has 
been attempted. 
Each crewmember will be required to participate in a 2-hour 
PRIVATE debriefing session with the P.I. and designated 
Co-investigators within 14 days postflight. Flight data tapes and 
diagnostic log books will have been returned to the P.I. within 
24 to 36 hours postflight. These data will be discussed with the 
crewmember during the subsequent debriefing. 
D. CREW TRAINING REQUIREMENTS: 
All crew training requirements are described under Preflight 
Requirements. 
DATA REQUIREMENTS 
1 .  . I * .  
~~ 
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All hardware, including inflight diagnostic scale log books 
and inflight data tapes, are to be returned to the P.I. or 
designated representative at the landing site within 24 to 36 
hours of landing. 
Complete investigator/crew member privacy will be maintained 
at all times. No information regarding a specific crewmember’s 
motion sickness susceptibility, preflight training or inflight 
performance will be released without written permission from the 
crewmember. 
Final reports and/or journal articles will describe data 
obtained both preflight and inflight without identifying specific 
individuals, using Data Identification Codes. 
